Literature DB >> 12534339

The isolation of an immortalized and tumorigenic cell line from p21WAF1 null mouse bladders.

Terence W McGarvey1, Trang B Nguyen, John E Tomaszewski, S Bruce Malkowicz.   

Abstract

Given a role for the deregulation of p21WAF1 in the progression of bladder tumors, we examined the growth of cultured urothelial cells from wild-type and p21WAF1 null bladders. Bladders were excised, minced from euthanized p21WAF1 and wild-type mice, treated overnight with dispase, and then placed into flasks coated with collagen type I in Dulbecco modified Eagle medium with 10% fetal calf serum. After an overnight incubation, the media was replaced with a serum-free media and a portion of explants were treated with 12-O-tetrade-canoylphorbol-13-acetate (TPA) on day 7 and continued for either 4 or 9 wk. The urothelial origin of any surviving epithelial cells was determined by reverse transcription-polymerase chain reaction (RT-PCR) using uroplakin II-specific primers, and the expression of the cell cycle-related proteins, p16INK4 and p19ARF, was examined by semiquantitative RT-PCR and Western blotting. Isolated wild-type and serially passaged p21WAF1 null epithelial-like cells were then injected subcutaneously into nude mice. We found that phorbol ester treatment at two different concentrations significantly enhanced uroepithelial colony formation from isolated wild-type mouse bladder tissue. On the other hand, significantly fewer urothelial colonies were derived from p21WAF1 null bladder cells treated with phorbol ester. Although there was apparent senescence and cell death of epithelial foci and stromal cells in phorbol ester-treated and -untreated p21WAF1 null cultures, after 3 mo there was an apparent subpopulation of epitheloid cells that overgrew each flask. There was a significant decrease in the number of these serially passaged cells in the G1 phase of the cell cycle when compared with initial explant wild-type or p21WAF1 null cells. This subpopulation of epitheloid cells expressed the mouse uroplakin II gene, indicating a urothelial phenotype, but did not express either the p16INKa or p19ARF proteins, whereas p21WAF1 null bladders express both proteins. There was also a high level of expression of the p53 protein and a significant decrease in the expression of the p19ARF transcript in both p21WAF1 null bladder and p21WAF1 null cells. These p21WAF1 null cells could be easily passaged and when injected subcutaneously into nude mice, large tumors developed. Therefore, it appears that a subpopulation of urothelial cells from the p21WAF1 null bladder can develop a tumorigenic phenotype in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12534339     DOI: 10.1290/1071-2690(2002)038<0394:TIOAIA>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  22 in total

1.  Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.

Authors:  S B Malkowicz; J E Tomaszewski; A J Linnenbach; T A Cangiano; Y Maruta; T W McGarvey
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

2.  Repair Defect in p21 WAF1/CIP1 -/- human cancer cells.

Authors:  E R McDonald; G S Wu; T Waldman; W S El-Deiry
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential.

Authors:  G I Topley; R Okuyama; J G Gonzales; C Conti; G P Dotto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.

Authors:  A Besson; V W Yong
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.

Authors:  W C Weinberg; N E Montano; C Deng
Journal:  Oncogene       Date:  1997-08-07       Impact factor: 9.867

7.  The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

Authors:  C Missero; F Di Cunto; H Kiyokawa; A Koff; G P Dotto
Journal:  Genes Dev       Date:  1996-12-01       Impact factor: 11.361

8.  Increased levels of p21WAF1/Cip1 in human brain tumors.

Authors:  J M Jung; J M Bruner; S Ruan; L A Langford; A P Kyritsis; T Kobayashi; V A Levin; W Zhang
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

9.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.

Authors:  J P Stein; D A Ginsberg; G D Grossfeld; S J Chatterjee; D Esrig; M G Dickinson; S Groshen; C R Taylor; P A Jones; D G Skinner; R J Cote
Journal:  J Natl Cancer Inst       Date:  1998-07-15       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.